Petr Novotný

Targeting of the Mitochondrial TET1 Protein by Pyrrolo[3,2-b]pyrrole Chelators

B. Masters, F. Vellieux, R. Kaplánek, 2022, International journal of molecular sciences.

The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

D. Mannino, G. Koppelman, B. Lipworth, 2021, The Lancet Respiratory Medicine.

Non-psychotropic cannabinoids as inhibitors of TET1 protein.

A. Goede, R. Preissner, M. Masařík, 2022, Bioorganic chemistry.

Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation

E. Daynes, P. Mehta, M. Toshner, 2023, The Lancet Respiratory Medicine.

TET protein inhibitors: Potential and limitations.

M. Masařík, P. Martásek, P. Babula, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

Thomas E. Nichols, Paul J. Harrison, Jennifer M. Brown, 2023, The Lancet. Respiratory medicine.

Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.

L. Wain, K. Rawlik, M. Halling-Brown, 2024, The lancet. Psychiatry.